Loomis, Sayles & Company
WVE icon

Loomis, Sayles & Company’s Wave Life Sciences WVE Stock Holding History

Loomis, Sayles & Company’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,040,223
Closed -$34.7M – 769
2025
Q4 		$34.7M Sell
2,040,223
-865,243
-30% -$8.79M 0.04% 155
2025
Q3 		$21.3M Sell
2,905,466
-390,234
-12% -$3.16M 0.03% 234
2025
Q2 		$21.4M Buy
3,295,700
+859,160
+35% +$5.67M 0.03% 232
2025
Q1 		$19.7M Buy
2,436,540
+775,674
+47% +$8.48M 0.03% 239
2024
Q4 		$20.5M Buy
+1,660,866
New +$22.2M 0.03% 248

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company's WVE Position: Q1 2026 in Review

Loomis, Sayles & Company sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 2,040,223 shares — an estimated $34.7M sold.

Loomis, Sayles & Company first reported a position in WVE in Q4 2024 and held it in 5 quarters. The position peaked at $34.7M in Q4 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Loomis, Sayles & Company reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Loomis, Sayles & Company sold 2,040,223 Wave Life Sciences shares in Q1 2026, an estimated $34.7M.
  • Loomis, Sayles & Company first reported a position in Wave Life Sciences in Q4 2024 and held it in 5 quarters.
  • Loomis, Sayles & Company's Wave Life Sciences position peaked at $34.7M in Q4 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.